Attr Amyloidosis Wild Type clinical trials

Explore recruiting attr amyloidosis wild type clinical trials.

Recruiting attr amyloidosis wild type studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Attr Amyloidosis Wild Type trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Attr Amyloidosis Wild Type trials by city

Attr Amyloidosis Wild Type in Toronto Attr Amyloidosis Wild Type in Vancouver Attr Amyloidosis Wild Type in Montreal Attr Amyloidosis Wild Type in Calgary Attr Amyloidosis Wild Type in Edmonton Attr Amyloidosis Wild Type in Ottawa Attr Amyloidosis Wild Type in Winnipeg Attr Amyloidosis Wild Type in Quebec City Attr Amyloidosis Wild Type in Hamilton Attr Amyloidosis Wild Type in Kitchener Attr Amyloidosis Wild Type in London Attr Amyloidosis Wild Type in Halifax Attr Amyloidosis Wild Type in New York Attr Amyloidosis Wild Type in Los Angeles Attr Amyloidosis Wild Type in Chicago Attr Amyloidosis Wild Type in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease